Amir Mohsenin, MD, PhD specializes in the medical and surgical management of diseases of the retina and vitreous including macular degeneration, diabetic retinopathy, inherited retinal diseases, retinal detachments, macular holes, epiretinal membranes and retinal vascular disease.
Dr. Mohsenin received his bachelor’s degree from the University of Pennsylvania. He was awarded a full scholarship to enroll in the competitive dual degree MD/PhD program at UTHealth’s McGovern Medical School. After graduation, he was accepted to the Yale University School of Medicine for ophthalmology residency. At Yale, he received the Sears Award for clinical and surgical excellence in ophthalmology.
Dr. Mohsenin went on to complete a 2-year vitreoretinal surgery fellowship at the Bascom Palmer Eye Institute, which has been ranked #1 by US News & World Report for more than a decade.
Dr. Mohsenin previously served as an Assistant Professor of Ophthalmology at UT Health where he trained numerous medical students and ophthalmology residents and received the Outstanding Clinical Faculty Award in 2019. In addition to taking care of patients while at UT Health, Dr. Mohsenin was awarded a $1 million grant from the National Institutes of Health (NIH) to develop new therapies for macular degeneration.
Dr. Mohsenin is board certified by the American Board of Ophthalmology and has authored numerous book chapters and scientific articles.